Vosoritide potentially life-saving for children with common form of dwarfism
HTML-код
- Опубликовано: 21 янв 2024
- Casper has achondroplasia, and has benefited from a new therapy involving the bone growth drug Vosoritide. This trial has been led by Professor Ravi Savarirayan at the Murdoch Children's Research Institute, with the treatment approved from birth in Australia.
Casser is adorable. Lots of love from Versailles in France ❤
Praying for a healing for him amen
You are the cutest young man i' ve ever seen
Sorry Casper
feel sorry for the parents
They must have someone in family with this?
В 80 % случаев ахондроплазия возникает в результате спонтанной мутации.
@@user-co7fo3wx8i English please